当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析 - 现金流量表

华海药业

(600521)

  

流通市值:254.83亿  总市值:254.83亿
流通股本:14.97亿   总股本:14.97亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,486,694,087.38,709,986,888.796,615,578,877.094,433,984,374.73
  收到的税费返还64,777,189.24216,564,223.97111,725,483.4157,310,887.51
  收到其他与经营活动有关的现金38,527,999.18245,623,358.44173,991,588.18106,817,061.35
  经营活动现金流入小计2,589,999,275.729,172,174,471.26,901,295,948.684,598,112,323.59
  购买商品、接受劳务支付的现金867,948,925.112,607,895,934.192,515,392,005.491,626,867,295.49
  支付给职工以及为职工支付的现金559,971,235.221,865,521,482.471,377,650,514.37950,118,265.94
  支付的各项税费172,558,207.83608,004,159.62498,566,565.7418,875,420
  支付其他与经营活动有关的现金590,888,293.982,860,664,326.031,857,300,190.981,232,613,629.63
  经营活动现金流出小计2,191,366,662.147,942,085,902.316,248,909,276.544,228,474,611.06
  经营活动产生的现金流量净额398,632,613.581,230,088,568.89652,386,672.14369,637,712.53
二、投资活动产生的现金流量:
  收回投资收到的现金-116,266,648.6116,266,648.6-
  取得投资收益收到的现金-2,276,291.74159,980.78159,980.78
  处置固定资产、无形资产和其他长期资产收回的现金净额4,092,6859,952,0063,042,212.21,194,460
  收到的其他与投资活动有关的现金-89,150,00075,150,00075,150,000
  投资活动现金流入小计4,092,685217,644,946.34194,618,841.5876,504,440.78
  购建固定资产、无形资产和其他长期资产支付的现金446,392,949.921,966,048,669.651,184,831,134.49770,274,761.71
  投资支付的现金-30,000,00030,000,00030,000,000
  支付其他与投资活动有关的现金134,418,652.989,150,00089,150,00075,150,000
  投资活动现金流出小计580,811,602.822,085,198,669.651,303,981,134.49875,424,761.71
  投资活动产生的现金流量净额-576,718,917.82-1,867,553,723.31-1,109,362,292.91-798,920,320.93
三、筹资活动产生的现金流量:
  吸收投资收到的现金-591,515,088.97591,515,088.97591,515,088.97
  取得借款收到的现金1,180,000,0004,725,846,856.913,454,074,156.911,353,233,056.91
  收到其他与筹资活动有关的现金-200,000,000200,000,000200,000,000
  筹资活动现金流入小计1,180,000,0005,517,361,945.884,245,589,245.882,144,748,145.88
  偿还债务支付的现金507,670,7374,303,857,9183,372,511,3831,517,095,000
  分配股利、利润或偿付利息支付的现金37,283,948.28558,051,627.45491,179,385.9684,217,751.93
  其中:子公司支付给少数股东的股利、利润-11,870,802.511,870,802.511,870,802.5
  支付其他与筹资活动有关的现金10,400,036.9938,382,608.7724,705,404.2814,392,338.63
  筹资活动现金流出小计555,354,722.274,900,292,154.223,888,396,173.241,615,705,090.56
  筹资活动产生的现金流量净额624,645,277.73617,069,791.66357,193,072.64529,043,055.32
四、汇率变动对现金及现金等价物的影响-47,290,591.29-10,650,693.14-10,772,784.367,777,954.17
五、现金及现金等价物净增加额399,268,382.2-31,046,055.9-110,555,332.49107,538,401.09
  加:期初现金及现金等价物余额1,446,554,164.111,477,600,220.011,477,600,220.011,477,600,220.01
  期末现金及现金等价物余额1,845,822,546.311,446,554,164.111,367,044,887.521,585,138,621.1
补充资料:
  净利润-227,329,393.11-405,158,861.54
  资产减值准备-205,463,675.96-54,290,859.75
  固定资产和投资性房地产折旧-888,153,436.39-428,986,750.01
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-888,153,436.39-428,986,750.01
  无形资产摊销-123,310,912.26-60,441,819.91
  长期待摊费用摊销-13,238,385.18-6,901,608.96
  处置固定资产、无形资产和其他长期资产的损失--943.66-14,072.93
  固定资产报废损失-13,497,071.17-2,626,083.63
  公允价值变动损失--48,739,845.24--32,699,755.78
  财务费用-267,297,570.98-110,204,782.05
  投资损失--20,710,977.24-12,094,720.76
  递延所得税--5,107,155.12-1,917,077.02
  其中:递延所得税资产减少--5,107,155.12-1,917,077.02
  存货的减少--471,605,242.36--233,596,825.81
  经营性应收项目的减少--126,337,241.49--135,192,077.57
  经营性应付项目的增加-165,021,079.43--330,549,917.98
  其他-8,312,103.96-6,457,221.72
  现金的期末余额-1,446,554,164.11-1,585,138,621.1
  减:现金的期初余额-1,477,600,220.01-1,477,600,220.01
  现金及现金等价物的净增加额--31,046,055.9-107,538,401.09
公告日期2026-04-302026-04-302025-10-312025-08-26
审计意见(境内)标准无保留意见
TOP↑